Simulations Plus, Inc. (SLP) reported third-quarter fiscal 2025 adjusted earnings of 45 cents per share, which expanded 66.7% year over year. The figure also surpassed the Zacks Consensus Estimate of ...

The company's recent performance was broadly in line with expectations; however, if its guidance is accurate, revenue and profitability could rise this fiscal year. For its fiscal fourth quarter of ...

Simulations Plus, Inc.SLP was a big mover last session, as the company saw its shares rise nearly 6% on the day. Shares gained after the company reported higher earnings and revenues for the third ...

The fiscal 2025 preliminary results and fiscal 2026 guidance set forth above are preliminary and unaudited based on currently available information and management estimates and are subject to ...

Simulations Plus faces soft revenue growth in the short term, due largely to macro conditions. The negatives appear to have been priced in, though, after a period of significant share price declines.

SUMMARY Simulations Plus(NASDAQ:SLP) reported mixed operational results for Q3 FY2025, as inorganic revenue gains from acquisitions were offset by organic decline and profitability was burdened by a ...

Simulations Plus, founded in 1996, has established itself as a key player in the bio-simulation market, second only to its larger competitor, Certara (NASDAQ:CERT). The company's business model is ...

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods ...